173 related articles for article (PubMed ID: 28913712)
1. Surgical Site Infection Is Associated with Tumor Recurrence in Patients with Extrahepatic Biliary Malignancies.
Buettner S; Ethun CG; Poultsides G; Tran T; Idrees K; Isom CA; Weiss M; Fields RC; Krasnick B; Weber SM; Salem A; Martin RCG; Scoggins CR; Shen P; Mogal HD; Schmidt C; Beal E; Hatzaras I; Shenoy R; Koerkamp BG; Maithel SK; Pawlik TM
J Gastrointest Surg; 2017 Nov; 21(11):1813-1820. PubMed ID: 28913712
[TBL] [Abstract][Full Text] [Related]
2. Failure to administer multimodality therapy leads to sub-optimal outcomes for patients with node-positive biliary tract cancers in the United States.
Sheka AC; Altman A; Marmor S; Hui JYC; Denbo JW; Ankeny JS; Jensen EH
Surg Oncol; 2020 Sep; 34():298-303. PubMed ID: 32891346
[TBL] [Abstract][Full Text] [Related]
3. Elevated CA 19-9 portends poor prognosis in patients undergoing resection of biliary malignancies.
Hatzaras I; Schmidt C; Muscarella P; Melvin WS; Ellison EC; Bloomston M
HPB (Oxford); 2010 Mar; 12(2):134-8. PubMed ID: 20495658
[TBL] [Abstract][Full Text] [Related]
4. Defining Early Recurrence of Hilar Cholangiocarcinoma After Curative-intent Surgery: A Multi-institutional Study from the US Extrahepatic Biliary Malignancy Consortium.
Zhang XF; Beal EW; Chakedis J; Chen Q; Lv Y; Ethun CG; Salem A; Weber SM; Tran T; Poultsides G; Son AY; Hatzaras I; Jin L; Fields RC; Buettner S; Scoggins C; Martin RCG; Isom CA; Idrees K; Mogal HD; Shen P; Maithel SK; Schmidt CR; Pawlik TM
World J Surg; 2018 Sep; 42(9):2919-2929. PubMed ID: 29404753
[TBL] [Abstract][Full Text] [Related]
5. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.
Primrose JN; Fox RP; Palmer DH; Malik HZ; Prasad R; Mirza D; Anthony A; Corrie P; Falk S; Finch-Jones M; Wasan H; Ross P; Wall L; Wadsley J; Evans JTR; Stocken D; Praseedom R; Ma YT; Davidson B; Neoptolemos JP; Iveson T; Raftery J; Zhu S; Cunningham D; Garden OJ; Stubbs C; Valle JW; Bridgewater J;
Lancet Oncol; 2019 May; 20(5):663-673. PubMed ID: 30922733
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled trial of perioperative antimicrobial therapy based on the results of preoperative bile cultures in patients undergoing biliary reconstruction.
Okamura K; Tanaka K; Miura T; Nakanishi Y; Noji T; Nakamura T; Tsuchikawa T; Okamura K; Shichinohe T; Hirano S
J Hepatobiliary Pancreat Sci; 2017 Jul; 24(7):382-393. PubMed ID: 28371248
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy with gemcitabine and S-1 after surgical resection for advanced biliary carcinoma: outcomes and prognostic factors.
Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakashima A; Sakabe R; Kobayashi H; Kondo N; Nakagawa N; Sueda T
J Hepatobiliary Pancreat Sci; 2012 Jul; 19(4):306-13. PubMed ID: 22270151
[TBL] [Abstract][Full Text] [Related]
9. Outcomes in biliary malignancy.
Groot Koerkamp B; Fong Y
J Surg Oncol; 2014 Oct; 110(5):585-91. PubMed ID: 25250887
[TBL] [Abstract][Full Text] [Related]
10. Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment.
Kondo S; Takada T; Miyazaki M; Miyakawa S; Tsukada K; Nagino M; Furuse J; Saito H; Tsuyuguchi T; Yamamoto M; Kayahara M; Kimura F; Yoshitomi H; Nozawa S; Yoshida M; Wada K; Hirano S; Amano H; Miura F; ; ;
J Hepatobiliary Pancreat Surg; 2008; 15(1):41-54. PubMed ID: 18274843
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of postoperative infection after resection of biliary malignancy: A multicenter retrospective cohort study.
Iseki M; Mizuma M; Unno M; Maruyama H; Akagi S; Shimoda M; Uemura K; Inoue T; Shiomi H; Watanabe M; Kobayashi M; Matsuda A; Mizuuchi Y; Aoki T; Shinkawa H; Takahata R; Makino K; Arai H; Yokoyama Y; Takeda S; Yaguchi Y; Kitagawa Y
Surgery; 2023 Nov; 174(5):1145-1152. PubMed ID: 37599194
[TBL] [Abstract][Full Text] [Related]
12. The Effects of Travel Burden on Outcomes After Resection of Extrahepatic Biliary Malignancies: Results from the US Extrahepatic Biliary Consortium.
O'Connor SC; Mogal H; Russell G; Ethun C; Fields RC; Jin L; Hatzaras I; Vitiello G; Idrees K; Isom CA; Martin R; Scoggins C; Pawlik TM; Schmidt C; Poultsides G; Tran TB; Weber S; Salem A; Maithel S; Shen P
J Gastrointest Surg; 2017 Dec; 21(12):2016-2024. PubMed ID: 28986752
[TBL] [Abstract][Full Text] [Related]
13. Does high-grade dysplasia/carcinoma in situ of the biliary duct margin affect the prognosis of extrahepatic cholangiocarcinoma? A meta-analysis.
Ke Q; Wang B; Lin N; Wang L; Liu J
World J Surg Oncol; 2019 Dec; 17(1):211. PubMed ID: 31818290
[TBL] [Abstract][Full Text] [Related]
14. Association of Perioperative Transfusion with Recurrence and Survival After Resection of Distal Cholangiocarcinoma: A 10-Institution Study from the US Extrahepatic Biliary Malignancy Consortium.
Lopez-Aguiar AG; Ethun CG; Pawlik TM; Tran T; Poultsides GA; Isom CA; Idrees K; Krasnick BA; Fields RC; Salem A; Weber SM; Martin RCG; Scoggins CR; Shen P; Mogal HD; Beal EW; Schmidt C; Shenoy R; Hatzaras I; Maithel SK
Ann Surg Oncol; 2019 Jun; 26(6):1814-1823. PubMed ID: 30877497
[TBL] [Abstract][Full Text] [Related]
15. Postoperative Infectious Complications Worsen Long-Term Survival After Curative-Intent Resection for Hepatocellular Carcinoma.
Wei T; Zhang XF; Bagante F; Ratti F; Marques HP; Silva S; Soubrane O; Lam V; Poultsides GA; Popescu I; Grigorie R; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
Ann Surg Oncol; 2022 Jan; 29(1):315-324. PubMed ID: 34378089
[TBL] [Abstract][Full Text] [Related]
16. Impact of the preoperative quantity and quality of skeletal muscle on outcomes after resection of extrahepatic biliary malignancies.
Okumura S; Kaido T; Hamaguchi Y; Fujimoto Y; Kobayashi A; Iida T; Yagi S; Taura K; Hatano E; Uemoto S
Surgery; 2016 Mar; 159(3):821-33. PubMed ID: 26603849
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of serum microRNA as a predictive marker of recurrence and prognosis in biliary tract cancer after radical surgery.
Akazawa Y; Mizuno S; Fujinami N; Suzuki T; Yoshioka Y; Ochiya T; Nakamoto Y; Nakatsura T
Sci Rep; 2019 Apr; 9(1):5925. PubMed ID: 30976046
[TBL] [Abstract][Full Text] [Related]
18. Differences in Prognostic Factors and Recurrence Patterns After Curative-Intent Resection of Perihilar and Distal Cholangiocarcinomas.
Sallinen V; Sirén J; Mäkisalo H; Lehtimäki TE; Lantto E; Kokkola A; Nordin A
Scand J Surg; 2020 Sep; 109(3):219-227. PubMed ID: 30791825
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and risk factors associated with surgical site infection after different types of hepatobiliary and pancreatic surgery.
Morikane K
Surg Today; 2017 Oct; 47(10):1208-1214. PubMed ID: 28303341
[TBL] [Abstract][Full Text] [Related]
20. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
Tran Cao HS; Zhang Q; Sada YH; Chai C; Curley SA; Massarweh NN
Cancer; 2018 Jan; 124(1):74-83. PubMed ID: 28841223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]